Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMINOUS: AI Agent-Assisted Support in Newly Diagnosed Metastatic Prostate Cancer
NCT07804030Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in prostate cancer (PCa) and anxiety disorder (2 arms), sponsored by Fudan University. Primary endpoint: Generalized Anxiety Disorder-7 at 2 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
prostate cancer (PCa)anxiety disorder
Beyond the preview
Go deeper on NCT07804030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804030.